Loading...
Loading...
In the last 30 days, the company did not witness any estimate revision while the Zacks Consensus Estimate moved lower, signaling trouble down the road. So make sure to keep an eye on this stock going forward to see if yesterday's move higher can last.
Flamel Technologies currently has a Zacks Rank #3 (Hold) while its Earnings ESP is positive.
Other well-performing stocks in the medical sector include WuXi PharmaTech (Cayman) Inc. WX, IntelliPharmaCeutics International IPCI and Cardiome Pharma Corp. CRME. All three carry a Zacks Rank #2 (Buy).
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report >>
CARDIOME PHARMA CRME: Get Free Report
FLAMEL TECH FLML: Free Stock Analysis Report
INTELLIPHARMACT IPCI: Free Stock Analysis Report
WUXI PHARMATECH WX: Free Stock Analysis Report
To read this article on Zacks.com click here.
Zacks Investment Research
Loading...
Loading...
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in